Experimental vaccine appears promising as a preventive of a rare HPV-linked cancer
An experimental vaccine against human papillomavirus—HPV—appears to be safe, and most importantly, benefits patients who develop a rare airway cancer that manifests as recurrent obstructive growths requiring dozens, sometimes, ...